SSAA09E1 – 10 mg

Brand:
Cayman
CAS:
433212-75-0
Storage:
-20
UN-No:
Non-Hazardous - /

SSAA09E1 is an inhibitor of severe acute respiratory syndrome coronavirus (SARS-CoV) viral entry.{58163} It reduces infection of HEK293T cells transiently transfected with angiotensin-converting enzyme 2 (ACE2) by an HIV-based virus system pseudotyped with SARS-CoV surface glycoprotein (EC50 = 6.7 μM). SSAA09E1 also inhibits the proteolytic activity of cathepsin L (IC50 = 5.33 µM) but not cathepsin B when used at a concentration of 20 µM.  

 

Available on backorder

SKU: 32582 - 10 mg Category:

Description

A SARS-CoV entry inhibitor; reduces infection of HEK293T cells transiently transfected with ACE2 by an HIV-based virus system pseudotyped with SARS-CoV surface glycoprotein (EC50 = 6.7 µM); inhibits the proteolytic activity of cathepsin L (IC50 = 5.33 µM)


Formal name: (2Z)-2-[1-(2-thienyl)ethylidene]-hydrazinecarbothioamide

Synonyms: 

Molecular weight: 199.3

CAS: 433212-75-0

Purity: ≥98%

Formulation: A crystalline solid